Clinical Trial Update: GV101 in Healthy Obese Participants [Phase 2]

View source ↗

Summary

Phase 2 trial of GV101 in healthy obese participants has completed. Sponsor: Graviton Bioscience Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• GV101

Snippet

Sponsor: Graviton Bioscience Corporation | Conditions: Weight Management | Phase 2 | Status: COMPLETED